The relationship between mean platelet volume, stroke subtype and clinical outcome

被引:101
作者
Butterworth, RJ [1 ]
Bath, PMW [1 ]
机构
[1] Kings Coll London, Sch Med & Dent, Dept Med, Stroke Res Grp, London SE5 9PJ, England
关键词
D O I
10.1080/09537109876429
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Platelets play a crucial role in the pathophysiology of atherothrombotic disease and are involved in the early thromboembolic phase of ischaemic stroke, Large platelets are known to be more active. We hypothesized that thrombomegaly would be limited to patients with cortical infarction as compared with patients with lacunar infarcts, and that it would be associated with functional outcome. Mean platelet volume (MPV) and platelet count (PC) were studied in 167 hospitalized patients with stroke within 48 h of symptom onset, and 65 age, gender and race matched controls. Stroke was clinically and radiologically sub-typed. MPV was significantly higher in patients with ischaemic stroke than the control group: mean (SD) 7.35 (1.05) vs 7.09 (0.74) fl, 2P = 0.04; this difference could be explained by MPV being higher in patients with cortical stroke: 7.46 (1.00) fl, 2P = 0.039, but not lacunar infarction: 7.14 (1.16) fl, 2P = 1.0, No difference was seen in PC between ischaemic patients and controls: 231 (82) 10(9)/l vs 236 (54) 10(9)/l, 2P = 0.63, MPV did not change at 3 months post-stroke in surviving patients with ischaemic stroke: 7.39 (1.03) fl vs 7.34 (0.97) fl, 2P = 0.53. Patients who were dead or dependent at 3 months had a significantly higher baseline MPV and a tendency to a lower PC than those who returned to independence. MPV and PC were not altered in patients with primary intracerebral haemorrhage. No differences in red cell volume was observed. Platelet volume is elevated in acute ischaemic stroke, a finding that persists at 3 months post-stroke and is limited to patients with cortical infarction, Thrombomegaly is a risk factor for a poor outcome after ischaemic stroke.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 29 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[3]  
BATH PMW, 1993, THROMB HAEMOSTASIS, V70, P687
[4]   Do acute stroke units improve care? [J].
Bath, PMW ;
Soo, J ;
Butterworth, RJ ;
Kerr, JE .
CEREBROVASCULAR DISEASES, 1996, 6 (06) :346-349
[5]   Platelet size: Measurement, physiology and vascular disease [J].
Bath, PMW ;
Butterworth, RJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) :157-161
[6]   Acute infection as a risk factor for ischemic stroke [J].
Bova, IY ;
Bornstein, NM ;
Korczyn, AD .
STROKE, 1996, 27 (12) :2204-2206
[7]  
BUTTERWORTH RJ, 1996, CEREBROVASC DIS, V6, P18
[8]   PLATELET COUNT, MEAN PLATELET VOLUME AND THEIR RELATION TO PROGNOSIS IN CEREBRAL INFARCTION [J].
DERASMO, E ;
ALIBERTI, G ;
CELI, FS ;
ROMAGNOLI, E ;
VECCI, E ;
MAZZUOLI, GF .
JOURNAL OF INTERNAL MEDICINE, 1990, 227 (01) :11-14
[9]   CAPSULAR INFARCTS - UNDERLYING VASCULAR-LESIONS [J].
FISHER, CM .
ARCHIVES OF NEUROLOGY, 1979, 36 (02) :65-73
[10]   INCREASED EXCRETION OF IMMUNOREACTIVE THROMBOXANE B2 IN CEREBRAL-ISCHEMIA [J].
FISHER, M ;
ZIPSER, R .
STROKE, 1985, 16 (01) :10-14